Abstract:Amyotrophic lateral sclerosis (ALS) is a fatal neurological disease characterized by progressive paralysis and ultimately respiratory failure within 5 years of symptom onset. Approximately 5–10% of ALS cases exhibit familial inheritance (FALS) and causative gene mutations can be found in 60% of FALS patients. The remaining 90–95% of ALS cases show sporadic manner (SALS) and mutations in the same genes are responsible for 10% of SALS patients. To date, rare variants in more than 30 genes have been reported to cause or be associated with ALS. Recently, Smith and et al. identified mutations in ANXA11 in ALS patients of European ancestry but pathogenicity of ANXA11 in other ALS cohorts remained unproved. In the current study, we investigated ANXA11 mutations in Chinese ALS patients with or without cognitive decline. A total of 383 Chinese ALS patients were recruited at ALS clinic of Neurology Department, Peking Union Medical College Hospital (PUMCH) from January 2016 to August 2017. All coding exons and at least 100 bp of flanking introns of ANXA11(NM_145869) were sequenced using ABI 3730 automated DNA-sequencing system. Rare variants (MAF < 0.1%) with high conservation were further assessed for pathogenicity using online prediction software including SIFT, PolyPhen2 and Mutation taster. ESEfinder 3.0 and Human Splicing Finder 3.0 were applied to predict the effect of mutation on mRNA splicing. Total RNA was extracted using TRIzol (Invitrogen) from peripheral white blood cells. Then 2.5 μg RNA were used to perform Reverse transcriptase-PCR. cDNA was amplified using primer pair ANXA11-RT-F(5′-CCATGAGCTACCCTGGCTAT-3′) and ANXA11-RT-R(5′-GACTCCCCAGGCAGTCAAT-3′) locating at ANXA11 exon 4 and exon 8 (shown in Fig. 3), respectively. The PCR products were isolated on a 1.5% agarose gel. DNA fragments of interest were gel-purified and sequenced. We identified 6 nonsynonymous heterozygous mutations (c.107C>G, p.P36R; c.119A>G, p.D40G; c.382G>A, p.V128M; c.687T>A, p.S229R; c.904C>T, p.R302C; c.1471G>A, p.G491R) and 1 splice-site mutation(c.174-2A>G, p.A58_Q187del) in 10 unrelated patients, accounting for a mutant frequency of 5.6% (1/18) in FALS, 2.3% (8/353) in SALS and 8.3% (1/12) in ALS-FTD. A novel p. P36R mutation was identified in one FALS index, one SALS patient and one ALS-FTD. The splicing mutation(c.174-2A>G) caused in-frame skipping of the entire exon 6 and further supported the loss-of-function mechanism. ANXA11 gene is the most frequently mutated genes in Chinese patients with SALS. The study findings further expand the ANXA11 phenotype, firstly highlighting its pathogenic role in ALS-FTD.

CHCHD10 Mutations in Patients with Amyotrophic Lateral Sclerosis in Mainland China.

Mutation Screening of the CHCHD10 Gene in Chinese Patients with Amyotrophic Lateral Sclerosis

Clinical Features and Cu/Zn Superoxide Dismutase Gene Mutations in Two Mainland Chinese Families with Amyotrophic Lateral Sclerosis

Mutation analysis of CHCHD10 in different neurodegenerative diseases.

Mutational Analysis of CHCHD2 in Chinese Patients with Multiple System Atrophy and Amyotrophic Lateral Sclerosis.

Neuropathologic Description of CHCHD10 Mutated Amyotrophic Lateral Sclerosis

Identification of CHCHD2 Mutations in Patients with Alzheimer's Disease, Amyotrophic Lateral Sclerosis and Frontotemporal Dementia in China.

Mutation Spectrum of Chinese Patients with Familial and Sporadic Amyotrophic Lateral Sclerosis

Genetic Spectrum and Variability in Chinese Patients with Amyotrophic Lateral Sclerosis.

Screening of SOD1, FUS and TARDBP Genes in Patients with Amyotrophic Lateral Sclerosis in Central-Southern China.

Mutation and Clinical Analysis of the CLCC1 Gene in Amyotrophic Lateral Sclerosis Patients from Central South China.

A Novel Potentially Pathogenic Rare Variant in the DNAJC7 Gene Identified in Amyotrophic Lateral Sclerosis Patients From Mainland China.

Identification of CHCHD10 Mutation in Chinese Patients with Alzheimer Disease

Dctn1 Gene Analysis In Chinese Patients With Sporadic Amyotrophic Lateral Sclerosis

Identification and Functional Analysis of Novel Mutations in the SOD1 Gene in Chinese Patients with Amyotrophic Lateral Sclerosis.

Mutation spectrum of amyotrophic lateral sclerosis in Central South China

ANXA11 Mutations Prevail in Chinese Amyotrophic Lateral Sclerosis Patients with and Without Cognitive Dementia (P1.320)

S55. ANXA11 Mutations Prevail in Chinese ALS Patients with and Without Cognitive Dementia

Mutation Analysis of MFSD8 in an Amyotrophic Lateral Sclerosis Cohort from Mainland China

Mutation Analysis of GLT8D1 and ARPP21 Genes in Amyotrophic Lateral Sclerosis Patients from Mainland China

Evaluation of Mitochondrial Function in CHCHD10 Mutation (P5.001)